Kate E Bärnighausen1,2, Sindy Matse3, Caitlin E Kennedy4, Charlotte L Lejeune5, Allison B Hughey5, Anita Hettema5, Till W Bärnighausen1,6, Shannon A McMahon1,4. 1. Faculty of Medicine, Institute for Global Health, University of Heidelberg, Heidelberg, Germany. 2. University of the Witwatersrand School of Public Health, Johannesburg, South Africa. 3. Eswatini Ministry of Health, Mbabane, Eswatini. 4. Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. 5. Clinton Health Access Initiative Eswatini, Mbabane, Eswatini. 6. Department of Global Health and Population, Harvard T.H. Chang School of Public Health, Boston, Massachusetts, USA.
Abstract
OBJECTIVE: To understand the relationship between HIV preexposure prophylaxis (PrEP) and resilience among Emaswati women. DESIGN: A qualitative study using semistructured in-depth interviews. METHODS: We interviewed 24 women who recently initiated PrEP at one of six public-sector primary-care clinics participating in a government demonstration project for PrEP for the general population, as well as 30 PrEP stakeholders from HIV policy, implementation and donor sectors. RESULTS: PrEP clients and stakeholders described an environment marked by high HIV risk. In this context, clients felt PrEP enhanced their resilience through feelings of protection, control over HIV acquisition, choice in relation to when to take PrEP, sexual pleasure and relief from the fear and consequences of HIV infection. Those in serodiscordant relationships described improved partner communication and a shared sense of responsibility for HIV prevention. Both PrEP clients and stakeholders asserted that PrEP marketing and communication should be Emaswati-led and community-owned. CONCLUSION: PrEP helps women in Eswatini envision longer, healthier and more fulfilled lives. PrEP enhances resilience through several pathways, including self-efficacy, choice, control over HIV infection and relief from the fear of HIV infection. Social marketing and information campaigns should not only focus on PrEP as an HIV-prevention method but also emphasize how PrEP has expanded choice, enhanced control and facilitated sexual enjoyment among PrEP clients.
OBJECTIVE: To understand the relationship between HIV preexposure prophylaxis (PrEP) and resilience among Emaswati women. DESIGN: A qualitative study using semistructured in-depth interviews. METHODS: We interviewed 24 women who recently initiated PrEP at one of six public-sector primary-care clinics participating in a government demonstration project for PrEP for the general population, as well as 30 PrEP stakeholders from HIV policy, implementation and donor sectors. RESULTS: PrEP clients and stakeholders described an environment marked by high HIV risk. In this context, clients felt PrEP enhanced their resilience through feelings of protection, control over HIV acquisition, choice in relation to when to take PrEP, sexual pleasure and relief from the fear and consequences of HIV infection. Those in serodiscordant relationships described improved partner communication and a shared sense of responsibility for HIV prevention. Both PrEP clients and stakeholders asserted that PrEP marketing and communication should be Emaswati-led and community-owned. CONCLUSION: PrEP helps women in Eswatini envision longer, healthier and more fulfilled lives. PrEP enhances resilience through several pathways, including self-efficacy, choice, control over HIV infection and relief from the fear of HIV infection. Social marketing and information campaigns should not only focus on PrEP as an HIV-prevention method but also emphasize how PrEP has expanded choice, enhanced control and facilitated sexual enjoyment among PrEP clients.
Authors: J Hanass-Hancock; S Hoffman; S Bergam; A D Harrison; N Benghu; S Khumalo; N Tesfay; T Exner; L Miller; C Dolezal Journal: AIDS Behav Date: 2022-02-26
Authors: Fernandos K Ongolly; Annabel Dolla; Kenneth Ngure; Elizabeth M Irungu; Josephine Odoyo; Elizabeth Wamoni; Kathryn Peebles; Kenneth Mugwanya; Nelly R Mugo; Elizabeth A Bukusi; Jennifer Morton; Jared M Baeten; Gabrielle O'Malley Journal: J Acquir Immune Defic Syndr Date: 2021-05-01 Impact factor: 3.771
Authors: Elzette Rousseau; Ariana W K Katz; Shannon O'Rourke; Linda-Gail Bekker; Sinead Delany-Moretlwe; Elizabeth Bukusi; Danielle Travill; Victor Omollo; Jennifer F Morton; Gabrielle O'Malley; Jessica E Haberer; Renee Heffron; Rachel Johnson; Connie Celum; Jared M Baeten; Ariane van der Straten Journal: PLoS One Date: 2021-10-14 Impact factor: 3.752
Authors: Tiara C Willie; Mauda Monger; Amy Nunn; Trace Kershaw; Jamila K Stockman; Kenneth H Mayer; Philip A Chan; Adaora A Adimora; Leandro A Mena; Deja Knight; Karlye A Philllips; Stefan D Baral Journal: BMC Infect Dis Date: 2021-10-26 Impact factor: 3.090
Authors: Elizabeth M Irungu; Kenneth Ngure; Kenneth K Mugwanya; Merceline Awuor; Annabelle Dollah; Fernandos Ongolly; Nelly Mugo; Elizabeth Bukusi; Elizabeth Wamoni; Josephine Odoyo; Jennifer F Morton; Gena Barnabee; Irene Mukui; Jared M Baeten; Gabrielle O'Malley Journal: AIDS Care Date: 2020-03-24
Authors: Astrid Berner-Rodoreda; Pascal Geldsetzer; Kate Bärnighausen; Anita Hettema; Till Bärnighausen; Sindy Matse; Shannon A McMahon Journal: PLoS One Date: 2020-09-23 Impact factor: 3.240